A study by researchers at Thomas Jefferson University and Sidney Kimmel Cancer Center – Jefferson Health demonstrates that although Black patients are now more likely to receive the most effective treatment in non-small cell lung cancer than a decade ago, disparities persist.
To access this subscriber-only content please log in or renew your subscription.
Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.
Login Subscribe
Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.
Login Subscribe